🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Juan W. Valle

University of Manchester

ORCID: 0000-0002-1999-0863

Also affiliated with Cancer Research UK Manchester Institute, Cholangiocarcinoma Foundation

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT‐3 and RADIANT‐4 trials”.

Relationship between metabolic toxicity and efficacy of everolimus in patients with neuroendocrine tumors: A pooled analysis from the randomized, phase 3 RADIANT‐3 and RADIANT‐4 trials

Cancer(2021)10.1002/cncr.33540

N/A

0DataRank · unranked

11 citations

Carlo Carnaghi, Roberto Buzzoni, Juan W. Valle, Fabian Herbst, Antonia Ridolfi +5 more

O-2 Phase III study of NUC-1031 + cisplatin vs gemcitabine + cisplatin for first-line treatment of patients with advanced biliary tract cancer (NuTide:121)

Annals of Oncology(2023)10.1016/j.annonc.2023.04.017

N/A

0DataRank · unranked

5 citations

I. Bazin, Do‐Youn Oh, O. Zubkov, V. Breder, Li‐Yuan Bai +16 more

Cholangiocarcinoma Targeted Therapies

American Journal Of Pathology(2024)10.1016/j.ajpath.2024.11.005

N/A

0DataRank · unranked

15 citations

Chiara Braconi, Juan W. Valle, Nabeel Bardeesy, Haley Ellis